goodplenty, it is for sure in line with the 'mini' version on the topic by PPHM CEO King two annuals ago.
He also, at a somewhat lower level, stated that it would be difficult to partner Bavi per type of treatment.
Illustrated with the story that reps would have to praise Bavi for the condition in which their company combines with it and kill it for the condition in which the competition combines with it.
That is in all case not done, if not extremely difficult to pull off without loosing face.
News 
Market Data 
Discover 
